|
Volumn 31, Issue 1-2, 1999, Pages 1246-1248
|
Can antibody prophylaxis allow sparing of other immunosuppressives?
a b c d e f g h i j |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCINEURIN;
CORTICOSTEROID;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
STEROID;
ADULT;
CONFERENCE PAPER;
DRUG EFFICACY;
FOLLOW UP;
GASTROINTESTINAL SYMPTOM;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMATOLOGIC DISEASE;
HUMAN;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY BIOPSY;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ACUTE DISEASE;
ADULT;
ANTIBODIES, MONOCLONAL;
CYTOMEGALOVIRUS INFECTIONS;
DRUG ADMINISTRATION SCHEDULE;
EUROPE;
GRAFT REJECTION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
MYCOPHENOLIC ACID;
POSTOPERATIVE COMPLICATIONS;
STEROIDS;
UNITED STATES;
|
EID: 0032986410
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01982-4 Document Type: Conference Paper |
Times cited : (54)
|
References (7)
|